Treatment Resistant Atopic Dermatitis: Challenges and Solutions [Corrigendum]
Johnson BB, Franco AI, Beck LA, Prezzano JC. Clin Cosmet Investig Dermatol. 2019; 12:181–192.On page 189, Ustekinumab section, “Ustekinumab is a human monoclonal antibody that binds to the shared p40 protein subunit of human IL-12 and IL-23, thereby preventing interaction with th...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-12-01
|
| Series: | Clinical, Cosmetic and Investigational Dermatology |
| Online Access: | https://www.dovepress.com/treatment-resistant-atopic-dermatitis-challenges-and-solutions-corrige-peer-reviewed-article-CCID |